We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

189 hedge funds and large institutions have $640M invested in Immunogen Inc in 2020 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 65 increasing their positions, 52 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

37% more capital invested

Capital invested by funds: $468M → $640M (+$172M)

25% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 52

15% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 26

11% more call options, than puts

Call options by funds: $891K | Put options by funds: $803K

2% more funds holding

Funds holding: 185 → 189 (+4)

Holders
189
Holders Change
+4
Holders Change %
+2.16%
% of All Funds
3.88%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
30
Increased
65
Reduced
52
Closed
26
Calls
$891K
Puts
$803K
Net Calls
+$88K
Net Calls Change
-$358K

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$17.7M
2
State Street
State Street
Massachusetts
+$14.7M
3
Millennium Management
Millennium Management
New York
+$8.54M
4
Ameriprise
Ameriprise
Minnesota
+$6.01M
5
Invesco
Invesco
Georgia
+$5.67M

Top Sellers

Rank Fund Capital Flow
1
RG
Redmile Group
California
-$20.1M
2
RCM
RA Capital Management
Massachusetts
-$17.6M
3
ACA
Avoro Capital Advisors
New York
-$6.48M
4
Renaissance Technologies
Renaissance Technologies
New York
-$5.75M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$4.84M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wellington Management Group
1
Wellington Management Group
Massachusetts
$107M +$17.7M +4,160,256 +22%
Vanguard Group
2
Vanguard Group
Pennsylvania
$68.6M -$4.84M -1,137,790 -7%
BlackRock
3
BlackRock
New York
$66.4M +$3.49M +821,410 +6%
RG
4
Redmile Group
California
$55.2M -$20.1M -4,726,900 -28%
Renaissance Technologies
5
Renaissance Technologies
New York
$44.5M -$5.75M -1,350,990 -12%
State Street
6
State Street
Massachusetts
$42.2M +$14.7M +3,457,441 +60%
ClearBridge Investments
7
ClearBridge Investments
New York
$35.6M -$2.4M -564,260 -7%
Millennium Management
8
Millennium Management
New York
$18.3M +$8.54M +2,007,736 +101%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$12.9M +$257K +60,434 +2%
D.E. Shaw & Co
10
D.E. Shaw & Co
New York
$11.8M +$937K +220,406 +9%
Northern Trust
11
Northern Trust
Illinois
$9.9M +$144K +33,796 +2%
PAM
12
Panagora Asset Management
Massachusetts
$8.41M +$973K +228,682 +14%
Goldman Sachs
13
Goldman Sachs
New York
$7.92M +$3.08M +724,894 +73%
Fidelity Investments
14
Fidelity Investments
Massachusetts
$7.24M +$489 +115 +0%
Ameriprise
15
Ameriprise
Minnesota
$6.61M +$6.01M +1,412,568 +5,747%
QF
16
QVT Financial
New York
$6.33M – – –
Wells Fargo
17
Wells Fargo
California
$6.29M +$985K +231,582 +20%
Invesco
18
Invesco
Georgia
$6.23M +$5.67M +1,334,164 +6,593%
HM
19
HealthCor Management
New York
$5.52M +$5.1M +1,200,000 New
Charles Schwab
20
Charles Schwab
California
$5.34M +$362K +85,155 +8%
Two Sigma Advisers
21
Two Sigma Advisers
New York
$5.08M +$424K +99,600 +10%
PA
22
Pinnacle Associates
New York
$5M -$46.7K -10,971 -1%
Two Sigma Investments
23
Two Sigma Investments
New York
$4.99M -$98.5K -23,157 -2%
N
24
Nuveen
North Carolina
$4.46M -$1.47M -345,483 -26%
Primecap Management
25
Primecap Management
California
$4.34M -$234K -55,000 -6%
1
2 3 4 5

IMGN Hedge Fund Activity: Q2 2020 in Review

189 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q2 2020, worth a combined $640M — up 37% from $468M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new IMGN positions and 26 closed out — a net gain of 4 holders — while 65 added to existing stakes and 52 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $17.7M. The largest seller was Redmile Group, cutting an estimated $20.1M.

  • 189 institutional investors held Immunogen Inc (IMGN) as of Q2 2020, up from 185 in Q1 2020.
  • Funds reported $640M of Immunogen Inc stock for Q2 2020, up 37% quarter-over-quarter.
  • 30 funds opened new Immunogen Inc positions in Q2 2020 and 26 closed out, a net change of +4 holders.
  • The largest Immunogen Inc buyer in Q2 2020 was Wellington Management Group, an estimated $17.7M added.
  • The largest Immunogen Inc seller in Q2 2020 was Redmile Group, an estimated $20.1M sold.

Based on aggregated 13F filings for Q2 2020.